Dataset from A Phase III, Randomized, Multicentre, Double-blind, Double-dummy, Parallel-group Comparative Study to Determine the Efficacy, Safety And Tolerability of Ceftazidime-Avibactam Versus Meropenem in the Treatment of Nosocomial Pneumonia Including Ventilator-Associated Pneumonia in Hospitalized Adults
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00010183
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to evaluate the effects of Ceftazidime-Avibactam compared to
Meropenem for treating hospitalized adults with nosocomial pneumonia including
ventilator-associated pneumonia
创建时间：
2025-08-09
